Related Experiment Video
Updated: May 16, 2026

04:33
Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Comparative validity of depression assessment scales for screening poststroke depression
Hee-Ju Kang1, Robert Stewart, Jae-Min Kim
1Department of Psychiatry, Chonnam National University Medical School and Depression Clinical Research Center, Chonnam National University Hospital, Gwangju, Republic of Korea.
Journal of Affective Disorders
|November 22, 2012
Summary
Four depression screening scales showed good accuracy for poststroke depression (PSD) at 2 weeks and 1 year. Misclassification varied by scale, stroke severity, and time post-stroke.
Area of Science:
- Neurology
- Psychiatry
- Clinical Assessment
Background:
- Post-stroke depression (PSD) is a common complication affecting patient recovery.
- Accurate screening for PSD is crucial for timely intervention.
- Existing screening tools may have varying performance and misclassification factors.
Purpose of the Study:
- To compare the screening performance of four common scales for PSD at 2 weeks and 1 year post-stroke.
- To identify factors contributing to misclassification of PSD by these scales.
- To inform the selection of appropriate screening tools in clinical practice.
Main Methods:
- A cohort of 423 stroke patients were assessed at 2 weeks, with 288 followed up at 1 year.
- Diagnosis of major and minor PSD was based on DSM-IV criteria.
- Screening scales included Beck Depression Inventory (BDI), HADS-D, HAMD, and MADRS.
- Receiver operating characteristic (ROC) analysis evaluated scale sensitivity and specificity.
Main Results:
- All scales demonstrated good discriminating ability for major and all PSD at both time points (AUCs 0.88-0.96).
- Misclassification was influenced by demographics and stroke severity, particularly for BDI and HAMD.
- Misclassification was more pronounced for all PSD compared to major PSD, and at 2 weeks versus 1 year post-stroke.
Conclusions:
- No significant differences in overall screening ability for PSD were observed among the scales.
- Factors influencing misclassification varied between scales, especially in the acute phase.
- Scales with fewer somatic items may be preferable for screening PSD, particularly early after stroke.
